restricted stock units

Tango Therapeutics grants new employee 367,500 stock options and 60,000 RSUs valued at $11.94 exercise price under inducement plan.

Pacira BioSciences awarded stock options and RSUs to three new employees totaling 7,900 shares at $22.10 exercise price under its inducement plan.

Penguin Solutions awards equity package including RSUs and performance-based PSUs to new Chief Product Officer, signaling strategic investment in product leadership.

BioCryst awards 65,850 RSUs to six new employees under Nasdaq inducement rule, vesting over four years starting March 2027.

Genmab corrects insider transaction report, fixing share price from DKK 0.00 to DKK 1,867.50 for executive RSU settlement.

Genmab A/S disclosed RSU vesting for top executives as part of deferred bonus arrangements, triggering mandatory insider trading disclosures under EU regulations.

Rent the Runway grants Executive Chair Fonseca 802K RSUs as an inducement award, vesting over three years to retain key talent.

Artiva Biotherapeutics appoints veteran pharma executive Thad Huston as CFO with 30+ years experience, ahead of key FDA feedback and clinical data milestones.

Cirrus Logic EVP sells $429K in stock amid strong earnings. Multiple executives engage in routine transactions, with the company's shares up 18% year-to-date.

TELA Bio granted 8,550 restricted stock units to three new hires, vesting over four years. The equity compensation aims to attract talent and promote retention.

Intuitive Machines CEO sold $1.4M in stock for tax purposes. Despite new Air Force contracts, the company remains unprofitable with declining revenue.

BridgeBio Pharma awarded 76,701 restricted stock units to 34 new employees as inducement grants under Nasdaq rules, vesting over four years with continued employment.